tenk.fyi

REPLIGEN CORP

RGENNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$738.3M

16.4% YoY

Net Income

$48.9M

291.6% YoY

EPS

$0.86

287.0% YoY

Cash

$566.0M

25.3% YoY

FY 2025 · As of 2025-12-31

No recent insider transactions found.

ProShowing last 90 days. Full 12+ month history available on Pro.
Upgrade